Actimab-A
Actimab-A Uses, Dosage, Side Effects, Food Interaction and all others data.
Actimab-A is under investigation in clinical trial NCT00016159 (Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia).
| Trade Name | Actimab-A |
| Generic | Lintuzumab |
| Lintuzumab Other Names | Lintuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Actimab-A
